Shandong Teamgene Technology Co. Ltd. A (603151) - Net Assets
Based on the latest financial reports, Shandong Teamgene Technology Co. Ltd. A (603151) has net assets worth CN¥1.44 Billion CNY (≈ $210.69 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.92 Billion ≈ $427.09 Million USD) and total liabilities (CN¥1.48 Billion ≈ $216.40 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Shandong Teamgene Technology Co. Ltd. A annual equity growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.44 Billion |
| % of Total Assets | 49.33% |
| Annual Growth Rate | 41.57% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 76.99 |
Shandong Teamgene Technology Co. Ltd. A - Net Assets Trend (2020–2024)
This chart illustrates how Shandong Teamgene Technology Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. See Shandong Teamgene Technology Co. Ltd. A (603151) net asset quality to measure how much of total assets are equity-financed.
Annual Net Assets for Shandong Teamgene Technology Co. Ltd. A (2020–2024)
The table below shows the annual net assets of Shandong Teamgene Technology Co. Ltd. A from 2020 to 2024. For live market cap and overall valuation, see market cap of Shandong Teamgene Technology Co. Ltd. A.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.28 Billion ≈ $187.47 Million |
+3.55% |
| 2023-12-31 | CN¥1.24 Billion ≈ $181.05 Million |
+0.60% |
| 2022-12-31 | CN¥1.23 Billion ≈ $179.97 Million |
+187.92% |
| 2021-12-31 | CN¥427.16 Million ≈ $62.51 Million |
+33.95% |
| 2020-12-31 | CN¥318.90 Million ≈ $46.66 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shandong Teamgene Technology Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 214.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥340.32 Million | 27.30% |
| Other Components | CN¥906.33 Million | 72.70% |
| Total Equity | CN¥1.25 Billion | 100.00% |
Shandong Teamgene Technology Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Shandong Teamgene Technology Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Brunel International NV
AS:BRNL
|
$353.34 Million |
|
Acco Brands Corporation
NYSE:ACCO
|
$353.35 Million |
|
Tera Light Ltd
TA:TRLT
|
$353.40 Million |
|
Brightstar Resources Ltd
AU:BTR
|
$353.42 Million |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
$353.29 Million |
|
Gigastorage Corp
TW:2406
|
$353.22 Million |
|
Aclaris Therapeutics Inc
NASDAQ:ACRS
|
$353.21 Million |
|
BrasilAgro - Companhia Brasileira de Propriedades Agrícolas
SA:AGRO3
|
$353.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shandong Teamgene Technology Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,228,127,000 to 1,246,649,313, a change of 18,522,313 (1.5%).
- Net income of 50,129,795 contributed positively to equity growth.
- Dividend payments of 40,007,825 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥50.13 Million | +4.02% |
| Dividends Paid | CN¥40.01 Million | -3.21% |
| Other Changes | CN¥8.40 Million | +0.67% |
| Total Change | CN¥- | 1.51% |
Book Value vs Market Value Analysis
This analysis compares Shandong Teamgene Technology Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.90x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.61x to 1.90x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CN¥2.51 | CN¥14.12 | x |
| 2021-12-31 | CN¥3.37 | CN¥14.12 | x |
| 2022-12-31 | CN¥7.31 | CN¥14.12 | x |
| 2023-12-31 | CN¥7.31 | CN¥14.12 | x |
| 2024-12-31 | CN¥7.42 | CN¥14.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shandong Teamgene Technology Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.02%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.97%
- • Asset Turnover: 1.41x
- • Equity Multiplier: 1.44x
- Recent ROE (4.02%) is below the historical average (18.06%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 35.33% | 6.49% | 3.59x | 1.52x | CN¥80.27 Million |
| 2021 | 34.32% | 7.17% | 3.70x | 1.29x | CN¥103.33 Million |
| 2022 | 9.81% | 7.26% | 1.19x | 1.13x | CN¥-2.39 Million |
| 2023 | 6.83% | 5.09% | 1.12x | 1.20x | CN¥-38.92 Million |
| 2024 | 4.02% | 1.97% | 1.41x | 1.44x | CN¥-74.54 Million |
Industry Comparison
This section compares Shandong Teamgene Technology Co. Ltd. A's net assets metrics with peer companies in the Farm Products industry.
Industry Context
- Industry: Farm Products
- Average net assets among peers: $2,080,537,850
- Average return on equity (ROE) among peers: -1.17%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shandong Teamgene Technology Co. Ltd. A (603151) | CN¥1.44 Billion | 35.33% | 1.03x | $353.30 Million |
| ShenZhen Kondarl Group Co Ltd (000048) | $708.75 Million | -21.95% | 4.51x | $1.70 Billion |
| Guangdong Guanghong Holdings Co Ltd (000529) | $1.57 Billion | 10.66% | 0.34x | $416.03 Million |
| Hunan Zhenghong Science and Technology Develop Co Ltd (000702) | $330.96 Million | -42.26% | 1.17x | $278.46 Million |
| Hefei Fengle Seed Co Ltd (000713) | $1.15 Billion | 4.75% | 0.60x | $685.64 Million |
| Luoniushan Co Ltd (000735) | $719.89 Million | 10.58% | 0.68x | $896.43 Million |
| New Hope Liuhe Co Ltd (000876) | $2.41 Billion | 7.36% | 0.59x | $4.71 Billion |
| Yuan Longping High-tech Agriculture Co Ltd (000998) | $6.27 Billion | 1.00% | 1.24x | $1.80 Billion |
| Dongrui Food Group Co Ltd (001201) | $3.10 Billion | 6.83% | 0.19x | $450.02 Million |
| Jiangxi Sunshine Dairy Co Ltd (001318) | $1.41 Billion | 8.10% | 0.05x | $464.91 Million |
| Shandong Denghai Seeds Co Ltd (002041) | $3.14 Billion | 3.25% | 0.20x | $1.15 Billion |
About Shandong Teamgene Technology Co. Ltd. A
Shandong Teamgene Technology Co., Ltd. engages in the research, development, production, and sale of pig feed that focuses on animal life and animal nutrition research in China. It offers pig feed, egg and poultry premixes, meat ruminant feed, and aquatic products, as well as sales veterinary drug. The company was founded in 2007 and is based in Zibo, China.